Page 102 - CIBEREHD2016-ENG
P. 102
LEAD rESEArCHEr
Navasa Anadon, Miquel Ángel
Hospital Clínico y Provincial de Barcelona
Villarroel, 170
08036 Barcelona
[email protected]
group Website
GROUP MEMBERS
Staff members: Gulfo Cabrales, José | Millán López, Olga | Muñóz Luque, Javier | Sabater Martínez, David Associated members: Brunet Serra, Mercedes | Colmenero Arroyo, Jordi Felix | Crespo Conde, Gonzalo | Fondevila Campo, Constantino | García-Valdecasas, Juan Carlos | Peralta Uroz, Carmen | Rimola Castella, Antoni | Rosello Catafau, Joan
Main lines of research
• Aloimmune response and immunosuppression. A new project will start aimed at evaluating the effect of alloreactivity on the evolution of the graft FISS: PI14/01055
• Ischemic reperfussion injury. evaluation of new ways of graft preservation. Brain death and its role in the ischemic preservation injury.
• Hepatitis C recurrence. Study of fibrosis regression after antiviral treatment. FISS: PI14/01055
• Complications of immunosuppression. Evaluation of a new protocol of immunosuppression: the effect
on graft rejection and kidney failure.
102
PROGRAMMES
P1
